Citation Impact
Citing Papers
Bridging the gaps in design methodologies by evolutionary optimization of the stability and proficiency of designed Kemp eliminase KE59
2012 StandoutNobel
Thermodynamic prediction of protein neutrality
2005 StandoutNobel
Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis
2007
Protein stability promotes evolvability
2006 StandoutNobel
Membrane-Type I Matrix Metalloproteinase-Dependent Regulation of Rheumatoid Arthritis Synoviocyte Function
2010
Neutrophil MMP-9 Proenzyme, Unencumbered by TIMP-1, Undergoes Efficient Activation in Vivo and Catalytically Induces Angiogenesis via a Basic Fibroblast Growth Factor (FGF-2)/FGFR-2 Pathway
2009
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
2017 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Activated KrasG12D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin
2011
Novel MMP-9 Substrates in Cancer Cells Revealed by a Label-free Quantitative Proteomics Approach
2008
The High Resolution Crystal Structure for Class A β-Lactamase PER-1 Reveals the Bases for Its Increase in Breadth of Activity
2000
Inflammation and cancer
2002 StandoutNature
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Matrix-dependent Proteolysis of Surface Transglutaminase by Membrane-type Metalloproteinase Regulates Cancer Cell Adhesion and Locomotion
2001
Mutagenesis of amino acid residues in the SHV-1 β-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance
2001
Role of the hemopexin domain of matrix metalloproteinases in cell migration
2008
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
A Common Core RNP Structure Shared between the Small Nucleoar Box C/D RNPs and the Spliceosomal U4 snRNP
2000 StandoutNobel
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: Contrasting, overlapping and compensatory functions
2009
Molecularly Engineered PEG Hydrogels: A Novel Model System for Proteolytically Mediated Cell Migration
2005
Two conserved domains of yeast U2 snRNA are separated by 945 nonessential nucleotides
1988
Systems Biology of Vascular Endothelial Growth Factors
2008
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Matrix Metalloproteinase-9 Promotes Chronic Lymphocytic Leukemia B Cell Survival through Its Hemopexin Domain
2010
Strategies for MMP inhibition in cancer: innovations for the post-trial era
2002
Evolution of an Antibiotic Resistance Enzyme Constrained by Stability and Activity Trade-offs
2002
The Hallmarks of Cancer
2000 Standout
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9
2012
Oxidative stress and the development of diabetic retinopathy: Contributory role of matrix metalloproteinase-2
2009
Gelatinase B: a tuner and amplifier of immune functions
2001
Acyl-intermediate Structures of the Extended-spectrum Class A β-Lactamase, Toho-1, in Complex with Cefotaxime, Cephalothin, and Benzylpenicillin
2002
The mouse telomerase RNA 5'-end lies just upstream of the telomerase template sequence
1998 StandoutNobel
Matrix Metalloproteinase 9 Promoter Activity Is Induced Coincident with Invasion during Tumor Progression
2000
Recent advances in MMP inhibitor design
2006
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
The microenvironment of the tumour–host interface
2001 StandoutNature
Quantitative Mass Spectrometry Reveals Dynamics of Factor-inhibiting Hypoxia-inducible Factor-catalyzed Hydroxylation
2011 StandoutNobel
Matrix metalloproteinases as modulators of inflammation and innate immunity
2004 Standout
Membrane Type 1-Matrix Metalloproteinase Is Activated during Migration of Human Endothelial Cells and Modulates Endothelial Motility and Matrix Remodeling
2001
MT1-MMP Initiates Activation of pro-MMP-2 and Integrin αvβ3 Promotes Maturation of MMP-2 in Breast Carcinoma Cells
2001
Antibiotic Resistance Is Prevalent in an Isolated Cave Microbiome
2012
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
A Simple Enantioconvergent and Chemoenzymatic Synthesis of Optically Active α‐Substituted Amides
2011 StandoutNobel
Alteration of the RNA polymerase specificity of U3 snRNA genes during evolution and in vitro
1991
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
2004
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
DNA-PKcs has KU-dependent function in rRNA processing and haematopoiesis
2020 StandoutNatureNobel
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
1989 StandoutNatureNobel
The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β
2006
Gene Expression Analysis of Zebrafish Heart Regeneration
2006
Pro-collagenase-1 (Matrix Metalloproteinase-1) Binds the α2β1 Integrin upon Release from Keratinocytes Migrating on Type I Collagen
2001
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
Matrix metalloproteinases in tumor–host cell communication
2002
Non-proteolytic, Receptor/Ligand Interactions Associate Cellular Membrane Type-1 Matrix Metalloproteinase with the Complement Component C1q
2004
A 20-year retrospective review of global aquaculture
2021 StandoutNature
Lectin Domains of Polypeptide GalNAc Transferases Exhibit Glycopeptide Binding Specificity
2011 StandoutNobel
Cancer-related inflammation
2008 StandoutNature
Retinal Neovascularization Is Suppressed With a Matrix Metalloproteinase Inhibitor
1999
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Changing views of the role of matrix metalloproteinases in metastasis
1997
Antibacterial drug discovery in the resistance era
2016 StandoutNature
Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation
2010 StandoutNature
Analysis of the structure of human telomerase RNA in vivo
2002
Matrix metalloproteinases and tumor metastasis
2006 Standout
The Activation of Carboxylic Acids via Self-Assembly Asymmetric Organocatalysis: A Combined Experimental and Computational Investigation
2016 StandoutNobel
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Evidence of Reciprocal Reorientation of the Catalytic and Hemopexin-Like Domains of Full-Length MMP-12
2008
A molecular switch underlies a human telomerase disease
2002 StandoutNobel
The yeast homologue of U3 snRNA.
1987
Cachectin and tumour necrosis factor as two sides of the same biological coin
1986 StandoutNatureNobel
Matrix Metalloproteinase Substrate Binding Domains, Modules and Exosites: Overview and Experimental Strategies
2003
In the light of directed evolution: Pathways of adaptive protein evolution
2009 StandoutNobel
Photodegradable Hydrogels for Dynamic Tuning of Physical and Chemical Properties
2009 StandoutScience
Catalytic Enantioselective Conversion of Epoxides to Thiiranes
2016 StandoutNobel
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
2013 StandoutNobel
Tissue Cells Feel and Respond to the Stiffness of Their Substrate
2005 StandoutScience
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Antimicrobial use in aquaculture re‐examined: its relevance to antimicrobial resistance and to animal and human health
2013
Lymphotoxin ? An immunologic hormone with anticarcinogenic and antitumor activity
1982
Functional Mapping of the U3 Small Nucleolar RNA from the Yeast Saccharomyces cerevisiae
1998
Isolation and sequencing of NOP1. A yeast gene encoding a nucleolar protein homologous to a human autoimmune antigen.
1990 StandoutNobel
Phase I and Pharmacologic Study of the Specific Matrix Metalloproteinase Inhibitor BAY 12-9566 on a Protracted Oral Daily Dosing Schedule in Patients With Solid Malignancies
2000
Hypoxia Promotes Murine Bone‐Marrow‐Derived Stromal Cell Migration and Tube Formation
2003
Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in Vitro
1985 StandoutScience
EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface.
2000
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Mutant TEM β-Lactamase Producing Resistance to Ceftazidime, Ampicillins, and β-Lactamase Inhibitors
2002
Regulation of Cell Invasion and Morphogenesis in a Three-Dimensional Type I Collagen Matrix by Membrane-Type Matrix Metalloproteinases 1, 2, and 3
2000
Chiral Phosphoric Acid Catalyzed Conversion of Epoxides into Thiiranes: Mechanism, Stereochemical Model, and New Catalyst Design
2021 StandoutNobel
Structures of Ceftazidime and Its Transition-State Analogue in Complex with AmpC β-Lactamase: Implications for Resistance Mutations and Inhibitor Design,
2001
Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1.
1996
The RNA Component of Human Telomerase
1995 StandoutScienceNobel
How Matrix Metalloproteinases Regulate Cell Behavior
2001 Standout
Recognition and Resistance in TEM β-Lactamase
2003
Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix.
1996
Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor
2005
Structural analysis of the human U3 ribonucleoprotein particle reveal a conserved sequence available for base pairing with pre-rRNA.
1987
Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
2001 Standout
Structural Analysis of the Human U3 Ribonucleoprotein Particle Reveal a Conserved Sequence Available for Base Pairing with Pre-rRna
1987
Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia
2009
Development of a Radiolabeled Probe for Detecting Membrane Type-1 Matrix Metalloproteinase on Malignant Tumors
2009
Works of Márta Tóth being referenced
The Inactive 44-kDa Processed Form of Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Enhances Proteolytic Activity via Regulation of Endocytosis of Active MT1-MMP
2008
Complex Pattern of Membrane Type 1 Matrix Metalloproteinase Shedding
2002
Processing, shedding, and endocytosis of membrane type 1‐matrix metalloproteinase (MT1‐MMP)
2004
Effects on Substrate Profile by Mutational Substitutions at Positions 164 and 179 of the Class A TEMpUC19 β-Lactamase from Escherichia coli
1999
Characterization of the Monomeric and Dimeric Forms of Latent and Active Matrix Metalloproteinase-9
2000
Regulation of membrane type-matrix metalloproteinases
2002
Cell surface association of matrix metalloproteinase-9 (gelatinase B)
2003
Biosynthesis of ?2(IV) and ?1(IV) chains of collagen IV and interactions with matrix metalloproteinase-9
1999
Binding of Active (57 kDa) Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) to Tissue Inhibitor of Metalloproteinase (TIMP)-2 Regulates MT1-MMP Processing and Pro-MMP-2 Activation
2000
Tissue Inhibitor of Metalloproteinase (TIMP)-2 Acts Synergistically with Synthetic Matrix Metalloproteinase (MMP) Inhibitors but Not with TIMP-4 to Enhance the (Membrane Type 1)-MMP-dependent Activation of Pro-MMP-2
2000
Potent Mechanism-based Inhibitors for Matrix Metalloproteinases
2005
High Affinity Binding of Latent Matrix Metalloproteinase-9 to the α2(IV) Chain of Collagen IV
1998
Molecular Structures and Dynamics of the Stepwise Activation Mechanism of a Matrix Metalloproteinase Zymogen: Challenging the Cysteine Switch Dogma
2007
Effects of Asp-179 mutations in TEMpUC19 beta-lactamase on susceptibility to beta-lactams
1995
Sulfonate-Containing Thiiranes as Selective Gelatinase Inhibitors
2010
An Antibiotic-Resistance Enzyme from a Deep-Sea Bacterium
2009
Plant small nuclear RNAs. Nucleolar U3 snRNA is present in plants: partial characterization
1985
Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells.
1997
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
1995
High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.
1996
The human lymphotoxin system—VI.
1979
Cleavage at the stem region releases an active ectodomain of the membrane type 1 matrix metalloproteinase
2005